The U.S. Food and Drug Administration has approved Guardant Health Inc.'s (NASDAQ: GH) Guardant360 Liquid CDx, a blood-based cancer testing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE